Therapies that deliver hydrogen sulfide to cells could one day become the basis of new treatments for obesity and related ...

Giving older Americans access to weight-loss medicines through the US Medicare program would cost $35 billion over nine years ...

A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...

The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...

Atlas Venture and Bain Capital Life Sciences are making their next bet in the buzzy obesity field, launching a new startup ...

Medicare is prohibited by law from covering GLP-1 drugs for weight loss. But many beneficiaries can access the drugs anyway.

Ilant estimates that behavioral therapy can help many people lose up to 5% of their weight, anti-obesity medications can help ...

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

As part of our series In Good Health, we discuss these new medications and the falling rate of obesity.

Addressing pediatric obesity requires a multifaceted ... Term Weight Loss in Patients Prescribed GLP-1 RA Medications Sep. 13, 2024 — A new study identified key factors that can impact the ...

Allowing Medicare to cover anti-obesity medications would drive up federal spending by about $35 billion on net between 2026 and 2034, according to ...

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...